Presenter: Rishi J. Desai, MS – Harvard Medical School/Brigham & Women's Hospital
@@@ David S. Carrell, PhD – Kaiser Permanente Washington Health Research Institute ### 1062836###Presenter######Kaiser Permanente Washington Health Research Institute###Presenter: David S. Carrell, PhD – Kaiser Permanente Washington Health Research Institute
@@@ Robert Ball, MPH, MD – US Food and Drug Administration ### 1359919###Presenter######US Food and Drug Administration###Presenter: Robert Ball, MPH, MD – US Food and Drug Administration
@@@ Katherine Liao – Brigham and Women's Hospital, Harvard Medical School ### 1360138###Co-Author###MD, MPH###Brigham and Women's Hospital, Harvard Medical School###Co-Author: Katherine Liao – Brigham and Women's Hospital, Harvard Medical School
@@@ Lindsay J. Collin – Rollins School of Public Health, Emory University ### 1360139###Presenter######Rollins School of Public Health, Emory University###Presenter: Lindsay J. Collin – Rollins School of Public Health, Emory University
@@@ Sebastian Schneeweiss, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA ### 1046819###Presenter######Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA###Presenter: Sebastian Schneeweiss, MD, ScD – Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachusetts, USA
WS-10Presenting Author: Patricia Saddier, MD, PhD – Merck & Co., Inc.
@@@ Kandace L. Amend – Optum ### 1063027###Co-Author###Epidemiologist###Optum###Co-Author: Kandace L. Amend – Optum
@@@ Morgan Marks – Pharmacoepidemiology Department, Merck & Co. Inc., Kenilworth, NJ, USA ### 1359188###Co-Author######Pharmacoepidemiology Department, Merck & Co. Inc., Kenilworth, NJ, USA###Co-Author: Morgan Marks – Pharmacoepidemiology Department, Merck & Co. Inc., Kenilworth, NJ, USA
@@@ Christine Velicer – Pharmacoepidemiology Department, Merck & Co. Inc., Kenilworth, NJ, USA ### 1359869###Co-Author######Pharmacoepidemiology Department, Merck & Co. Inc., Kenilworth, NJ, USA###Co-Author: Christine Velicer – Pharmacoepidemiology Department, Merck & Co. Inc., Kenilworth, NJ, USA
@@@ John D. Seeger, PharmD, FISPE – Optum Epidemiology ### 1046832###Co-Author######Optum Epidemiology###Co-Author: John D. Seeger, PharmD, FISPE – Optum Epidemiology
SP17CPresenting Author: Adebola Ajao – US Food and Drug Administration
@@@ Austin Cosgrove – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 1359038###Co-Author######Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###Co-Author: Austin Cosgrove – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
@@@ Efe Eworuke – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration ### 1062586###Co-Author######Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration###Co-Author: Efe Eworuke – Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration
@@@ Mohamed Mohamoud – Foof and Drug Administration ### 1359043###Co-Author######Foof and Drug Administration###Co-Author: Mohamed Mohamoud – Foof and Drug Administration
@@@ Rongmei Zhang – Food and Drug Administration ### 1359044###Co-Author######Food and Drug Administration###Co-Author: Rongmei Zhang – Food and Drug Administration
@@@ Oren Shapira – Harvard Pilgrim Health Care Institute ### 1359045###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: Oren Shapira – Harvard Pilgrim Health Care Institute
@@@ Joy Kolonoski – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute ### 1358128###Co-Author######Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute###Co-Author: Joy Kolonoski – Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute
@@@ John G. Connolly – Harvard Pilgrim Health Care Institute ### 1063038###Co-Author######Harvard Pilgrim Health Care Institute###Co-Author: John G. Connolly – Harvard Pilgrim Health Care Institute
SP12HCo-Author: Emily holthuis – PHARMO Institute for Drug Outcomes Research, Utrecht, Netherlands
@@@ Elisabeth Smits – PHARMO Institute ### 1358326###Presenting Author######PHARMO Institute###Presenting Author: Elisabeth Smits – PHARMO Institute
@@@ Dominik Beier – InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH, Berlin, Germany ### 1360299###Co-Author######InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH, Berlin, Germany###Co-Author: Dominik Beier – InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH, Berlin, Germany
@@@ Dirk Enders – InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH, Berlin, Germany ### 1360242###Co-Author######InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH, Berlin, Germany###Co-Author: Dirk Enders – InGef - Institut für angewandte Gesundheitsforschung Berlin GmbH, Berlin, Germany
@@@ Rosa Gini – Agenzia regionale di sanità della Toscana, Osservatorio di epidemiologia, Florence, Italy ### 1302758###Co-Author###Researcher/statistician###Agenzia regionale di sanità della Toscana, Osservatorio di epidemiologia, Florence, Italy###Co-Author: Rosa Gini – Agenzia regionale di sanità della Toscana, Osservatorio di epidemiologia, Florence, Italy
@@@ Claudia C. Bartolini – ARS Toscana ### 1063227###Co-Author######ARS Toscana###Co-Author: Claudia C. Bartolini – ARS Toscana
@@@ Giampiero Mazzaglia – Center for Public Health Research (CESP), University of Milan – Bicocca, Milan, Italy ### 1358940###Co-Author###Professor###Center for Public Health Research (CESP), University of Milan – Bicocca, Milan, Italy###Co-Author: Giampiero Mazzaglia – Center for Public Health Research (CESP), University of Milan – Bicocca, Milan, Italy
@@@ Fernie J. Penning- van Beest – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands ### 1358902###Co-Author######PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands###Co-Author: Fernie J. Penning- van Beest – PHARMO Institute for Drug Outcomes Research, Utrecht, the Netherlands
@@@ Georgios Spentzouris – Daiichi-Sankyo Europe GmbH, Munich, Germany ### 1360300###Co-Author######Daiichi-Sankyo Europe GmbH, Munich, Germany###Co-Author: Georgios Spentzouris – Daiichi-Sankyo Europe GmbH, Munich, Germany
@@@ Ron M.C. Herings, PharmD, PhD, FISPE – PHARMO Institute ### 1358325###Co-Author###Director###PHARMO Institute###Co-Author: Ron M.C. Herings, PharmD, PhD, FISPE – PHARMO Institute
OP-25FPresenting Author: Rachael K. Ross – University of North Carolina
@@@ Michele Jonsson Funk – University of North Carolina at Chapel Hill ### 1046824###Co-Author###Associate Professor###University of North Carolina at Chapel Hill###Co-Author: Michele Jonsson Funk – University of North Carolina at Chapel Hill
@@@ I-Hsuan Su – University of North Carolina ### 1397914###Co-Author######University of North Carolina###Co-Author: I-Hsuan Su – University of North Carolina
PP-01DPresenting Author: Xiao Zhang – Merck & Co., Inc.
@@@ Mehmet Burcu – Merck & Co., Inc. ### 1088178###Co-Author######Merck & Co., Inc.###Co-Author: Mehmet Burcu – Merck & Co., Inc.
@@@ Lei Chen – Merck & Co., Inc. ### 1358829###Co-Author######Merck & Co., Inc.###Co-Author: Lei Chen – Merck & Co., Inc.
@@@ Oswaldo L Bracco – Merck & Co., Inc. ### 1358830###Co-Author######Merck & Co., Inc.###Co-Author: Oswaldo L Bracco – Merck & Co., Inc.
@@@ Wei Zhou, MD, Ph.D – Merck & Co., Inc. ### 1062524###Co-Author###Executive Director###Merck & Co., Inc.###Co-Author: Wei Zhou, MD, Ph.D – Merck & Co., Inc.
SP05CPresenting Author: Marie Al Rahmoun – Paris Saclay
@@@ Reza Ghiasvand – Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Department of Research - Cancer Registry of Norway, Institute of Population-Based Cancer Research ### 1359483###Co-Author######Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Department of Research - Cancer Registry of Norway, Institute of Population-Based Cancer Research###Co-Author: Reza Ghiasvand – Oslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Department of Research - Cancer Registry of Norway, Institute of Population-Based Cancer Research
@@@ Manon Cairat – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP ### 1093487###Co-Author######Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP###Co-Author: Manon Cairat – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP
@@@ Yahya Mahamat-Saleh – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP ### 1359488###Co-Author######Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP###Co-Author: Yahya Mahamat-Saleh – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP
@@@ Gianluca Severi – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP - Department of Statistics, Computer Science and Applications “G. Parenti”, University of Florence ### 1359490###Co-Author######Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP - Department of Statistics, Computer Science and Applications “G. Parenti”, University of Florence###Co-Author: Gianluca Severi – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP - Department of Statistics, Computer Science and Applications “G. Parenti”, University of Florence
@@@ Marie-Christine Boutron-Ruault – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP ### 1359491###Co-Author######Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP###Co-Author: Marie-Christine Boutron-Ruault – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP
@@@ Trude Eid Robsahm – Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research ### 1359492###Co-Author######Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research###Co-Author: Trude Eid Robsahm – Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research
@@@ Marina Kvaskoff – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP ### 1359493###Co-Author######Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP###Co-Author: Marina Kvaskoff – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP
@@@ Agnès Fournier – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP ### 1093449###Co-Author######Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP###Co-Author: Agnès Fournier – Université Paris-Saclay, UVSQ, Univ. Paris-Sud, Inserm, Gustave Roussy, "Exposome and Heredity" team, CESP
SP05BCo-Author: Melinda Magyari, MD, PhD – Danish Multiple Sclerosis Center and The Danish Multiple Sclerosis Registry, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark
@@@ Nicholas Moore, MD, PhD – Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, 33000 Bordeaux, France ### 1063020###Co-Author######Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, 33000 Bordeaux, France###Co-Author: Nicholas Moore, MD, PhD – Univ. Bordeaux, INSERM CIC-P 1401, Bordeaux PharmacoEpi, 33000 Bordeaux, France
@@@ Stig Wergeland, MD, PhD – Department of Neurology, Haukeland University Hospital, Bergen Norway ### 1397890###Co-Author######Department of Neurology, Haukeland University Hospital, Bergen Norway###Co-Author: Stig Wergeland, MD, PhD – Department of Neurology, Haukeland University Hospital, Bergen Norway
@@@ Jaak Sõnajalg, MSc – Global Database Studies, IQVIA, Tartu Estonia ### 1397891###Co-Author######Global Database Studies, IQVIA, Tartu Estonia###Co-Author: Jaak Sõnajalg, MSc – Global Database Studies, IQVIA, Tartu Estonia
@@@ Meritxell Sabid – Merck KGaA ### 1360045###Presenting Author######Merck KGaA###Presenting Author: Meritxell Sabid – Merck KGaA
@@@ Aida Aydemir, MSc – Global Biostatistics, EMD Serono Research and Development Institute Inc., Billerica, MA, United States (a business of Merck KGaA, Darmstadt, Germany) ### 1397892###Co-Author######Global Biostatistics, EMD Serono Research and Development Institute Inc., Billerica, MA, United States (a business of Merck KGaA, Darmstadt, Germany)###Co-Author: Aida Aydemir, MSc – Global Biostatistics, EMD Serono Research and Development Institute Inc., Billerica, MA, United States (a business of Merck KGaA, Darmstadt, Germany)
@@@ Irene Bezemer, PhD – Global Epidemiology and Outcomes Research, IQVIA, Amsterdam, the Netherlands ### 1397893###Co-Author######Global Epidemiology and Outcomes Research, IQVIA, Amsterdam, the Netherlands###Co-Author: Irene Bezemer, PhD – Global Epidemiology and Outcomes Research, IQVIA, Amsterdam, the Netherlands
@@@ Tjalf Ziemssen, MD – Center of Clinical Neuroscience (T.Z.), Neurological University Clinic Carl Gustav Carus, University of Technology, Dresden, Germany ### 1397894###Co-Author######Center of Clinical Neuroscience (T.Z.), Neurological University Clinic Carl Gustav Carus, University of Technology, Dresden, Germany###Co-Author: Tjalf Ziemssen, MD – Center of Clinical Neuroscience (T.Z.), Neurological University Clinic Carl Gustav Carus, University of Technology, Dresden, Germany
@@@ Jens Kuhle, MD, PhD – Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital of Basel, Basel Switzerland ### 1397895###Co-Author######Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital of Basel, Basel Switzerland###Co-Author: Jens Kuhle, MD, PhD – Neurology Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital of Basel, Basel Switzerland
@@@ Merja Soilu-Hänninen, MD, PhD – Turku University Hospital Neurocenter and Department of Neurology, University of Turku, Turku Finland ### 1397896###Co-Author######Turku University Hospital Neurocenter and Department of Neurology, University of Turku, Turku Finland###Co-Author: Merja Soilu-Hänninen, MD, PhD – Turku University Hospital Neurocenter and Department of Neurology, University of Turku, Turku Finland
@@@ Helmut Butzkueven, MBBS, PhD, FRACP – Monash University, Melbourne, VIC, Australia ### 1397897###Co-Author######Monash University, Melbourne, VIC, Australia###Co-Author: Helmut Butzkueven, MBBS, PhD, FRACP – Monash University, Melbourne, VIC, Australia
@@@ Jan Hillert, MD, PhD – Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden ### 1397898###Co-Author######Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden###Co-Author: Jan Hillert, MD, PhD – Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden
SP07B